These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 34428532)

  • 1. Association between topical corticosteroid use and fracture risk among pediatric patients with atopic dermatitis.
    Imhof RL; Weaver AL; St Sauver J; Hand J; Davis DMR; Tollefson MM
    J Am Acad Dermatol; 2022 Aug; 87(2):409-411. PubMed ID: 34428532
    [No Abstract]   [Full Text] [Related]  

  • 2. Harmonised topical treatment procedures for children with atopic dermatitis.
    Løvold Berents TV; Dotterud C; Faleide EA; Fuskeland KK; Gildestad T; Gundersen SC; Haavik L; Helland L; Lange E; Lossius AH; Martinsen E; Olset H; Olstad IG; Rehbinder EM; Reier-Nilsen T; Endre KMAS; Schopf TR; Haugen Østhus BE
    Tidsskr Nor Laegeforen; 2024 Jun; 144(7):. PubMed ID: 38832604
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of total excipients of topical corticosteroids marketed in Korea.
    Choi J; Lee JJ; Lee H; Byun JY; Choi YW; Roh JY; Choi HY
    Contact Dermatitis; 2024 May; 90(5):532-534. PubMed ID: 38308325
    [No Abstract]   [Full Text] [Related]  

  • 4. A guide to improving the design and analysis of observational studies on the long-term safety of topical corticosteroids.
    Drucker AM; Austin PC; Harvey J; Lax SJ; Tadrous M; Thomas KS
    Br J Dermatol; 2024 Apr; 190(5):767-769. PubMed ID: 38366624
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial Comment: Corticosteroid Injections Are Safe, but They Have Side Effects That Must Be Known and Explained.
    Del Cura JL
    AJR Am J Roentgenol; 2024 Mar; 222(3):e2330780. PubMed ID: 38170835
    [No Abstract]   [Full Text] [Related]  

  • 6. New insights on ocular surface disease in patients with atopic dermatitis treated with dupilumab.
    Bortoluzzi P; Ferrucci S; Galimberti D; Garavelli F; Pozzo Giuffrida F; Pizzati A; Marzano AV; Mapelli C
    Br J Dermatol; 2022 Jan; 186(1):186-187. PubMed ID: 34431510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK inhibitors in the treatment of atopic dermatitis.
    Chovatiya R; Paller AS
    J Allergy Clin Immunol; 2021 Oct; 148(4):927-940. PubMed ID: 34437922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Real-World Data to Evaluate the Association Between Atopic Dermatitis and Cardiovascular Disease: A Retrospective Claims Analysis.
    Wu JJ; Amand C; No DJ; Mahajan P; Gadkari A; Ghorayeb E; Kaur M; Korotzer A; Eckert L
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1707-1715. PubMed ID: 34449070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Atopic Dermatitis and Mental Health Outcomes Across Childhood: A Longitudinal Cohort Study.
    Kern C; Wan J; LeWinn KZ; Ramirez FD; Lee Y; McCulloch CE; Langan SM; Abuabara K
    JAMA Dermatol; 2021 Oct; 157(10):1200-1208. PubMed ID: 34468686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unmet needs in atopic dermatitis management: an expert consensus.
    Patrizi A; Costanzo A; Patruno C; Busà VM; Chiricozzi A; Girolomoni G
    J Dermatolog Treat; 2022 Aug; 33(5):2459-2465. PubMed ID: 34445932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Care for children with atopic dermatitis in the Netherlands during the COVID-19 pandemic: Lessons from the first wave and implications for the future.
    Ragamin A; de Wijs LEM; Hijnen DJ; Arends NJT; Schuttelaar MLA; Pasmans SGMA; Bronner MB
    J Dermatol; 2021 Dec; 48(12):1863-1870. PubMed ID: 34459024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis.
    Li C; Sun X; Zhao K; Meng F; Li L; Mu Z; Han X
    Dermatology; 2022; 238(4):725-735. PubMed ID: 34455413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjunctival inflammation in dupilumab-treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines: A case series study.
    Bakker DS; Ter Linde JJM; Amini MM; Ariëns LFM; van Luijk CM; de Bruin-Weller MS; Thijs JL; Vercoulen Y; van Wijk F
    Allergy; 2021 Dec; 76(12):3814-3817. PubMed ID: 34449906
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase 2b, randomized, double-blind, multicenter, vehicle-controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild-to-moderate atopic dermatitis.
    Fujita K; Yagi M; Moriwaki S; Yoshida M; Graham D
    J Dermatol; 2021 Nov; 48(11):1640-1651. PubMed ID: 34435694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.
    Guttman-Yassky E; Renert-Yuval Y; Bares J; Chima M; Hawkes JE; Gilleaudeau P; Sullivan-Whalen M; Singer GK; Garcet S; Pavel AB; Lebwohl MG; Krueger JG
    Allergy; 2022 Mar; 77(3):897-906. PubMed ID: 34460948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Societal Costs of Moderate-to-severe Atopic Dermatitis Occurring in Adulthood: A Danish Register-based Study.
    Thyssen JP; Brenneche AW; Madsen ME; Pedersen MH; Trangbaek DJ; Vestergaard C
    Acta Derm Venereol; 2021 Sep; 101(9):adv00538. PubMed ID: 34458924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory Safety of Dupilumab in Patients Aged 6-11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial.
    Paller AS; Wollenberg A; Siegfried E; Thaçi D; Cork MJ; Arkwright PD; Gooderham M; Sun X; O'Malley JT; Khokhar FA; Vakil J; Bansal A; Rosner K; Shumel B; Levit NA
    Paediatr Drugs; 2021 Sep; 23(5):515-527. PubMed ID: 34462864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Uncharacteristic Presentation of Evans Syndrome Following Treatment With Dupilumab.
    Rutherford M; Tran M; Salazar L; Iqbal F; Mazharuddin A; Camarena J
    Cureus; 2021 Jul; 13(7):e16658. PubMed ID: 34462689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis.
    Sliz E; Huilaja L; Pasanen A; Laisk T; Reimann E; Mägi R; ; ; Hannula-Jouppi K; Peltonen S; Salmi T; Koulu L; Tasanen K; Kettunen J
    J Allergy Clin Immunol; 2022 Mar; 149(3):1105-1112.e9. PubMed ID: 34454985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Unmet Needs in Atopic Dermatitis Control in Latin America: A Multidisciplinary Expert Perspective.
    Sanchez J; Cherrez-Ojeda I; Galvan C; Garcia E; Hernández-Mantilla N; Londoño Garcia A; McElwee E; Rico Restrepo M; Rivas E; Hidalgo B
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1521-1540. PubMed ID: 34449071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.